Atlas Trials

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

Clinical trial NCT03568136 · COMPLETED

Trial details

NCT number
NCT03568136
Sponsor
GWT-TUD GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dermatitis, AtopicEczema, AtopicNeurodermatitis, Atopic
Start date
2018-09-18
Primary completion
2020-05-04
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.